20 related articles for article (PubMed ID: 38565142)
1. Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8
Ping Y; Shan J; Liu Y; Liu F; Wang L; Liu Z; Li J; Yue D; Wang L; Chen X; Zhang Y
Cancer Immunol Immunother; 2023 Apr; 72(4):1015-1027. PubMed ID: 36261540
[TBL] [Abstract][Full Text] [Related]
2. Function of taurine transporter (Slc6a6/TauT) as a GABA transporting protein and its relevance to GABA transport in rat retinal capillary endothelial cells.
Tomi M; Tajima A; Tachikawa M; Hosoya K
Biochim Biophys Acta; 2008 Oct; 1778(10):2138-42. PubMed ID: 18501699
[TBL] [Abstract][Full Text] [Related]
3. Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer.
Yasunaga M; Matsumura Y
Sci Rep; 2014 Apr; 4():4852. PubMed ID: 24781822
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 receptor signaling promotes the maintenance of a PD-1
Hanna BS; Llaó-Cid L; Iskar M; Roessner PM; Klett LC; Wong JKL; Paul Y; Ioannou N; Öztürk S; Mack N; Kalter V; Colomer D; Campo E; Bloehdorn J; Stilgenbauer S; Dietrich S; Schmidt M; Gabriel R; Rippe K; Feuerer M; Ramsay AG; Lichter P; Zapatka M; Seiffert M
Immunity; 2021 Dec; 54(12):2825-2841.e10. PubMed ID: 34879221
[TBL] [Abstract][Full Text] [Related]
5. Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells.
Tran TT; Mu A; Adachi Y; Adachi Y; Taketani S
Photochem Photobiol; 2014; 90(5):1136-43. PubMed ID: 24842606
[TBL] [Abstract][Full Text] [Related]
6. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
Front Immunol; 2020; 11():622509. PubMed ID: 33633741
[TBL] [Abstract][Full Text] [Related]
7. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8
Cao T; Zhang W; Wang Q; Wang C; Ma W; Zhang C; Ge M; Tian M; Yu J; Jiao A; Wang L; Liu M; Wang P; Guo Z; Zhou Y; Chen S; Yin W; Yi J; Guo H; Han H; Zhang B; Wu K; Fan D; Wang X; Nie Y; Lu Y; Zhao X
Cell; 2024 Apr; 187(9):2288-2304.e27. PubMed ID: 38565142
[TBL] [Abstract][Full Text] [Related]
8. Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity.
Andrews AM; Tennant MD; Thaxton JE
Cancer Immunol Immunother; 2021 May; 70(5):1165-1175. PubMed ID: 33104836
[TBL] [Abstract][Full Text] [Related]
9. The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress.
Rozpedek W; Pytel D; Mucha B; Leszczynska H; Diehl JA; Majsterek I
Curr Mol Med; 2016; 16(6):533-44. PubMed ID: 27211800
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
